Loss of HER2‐positivity following neoadjuvant targeted therapy for breast cancer is not associated with inferior oncologic outcomes.

Details

Language :

English

ISSN :

00224790

Volume :

124

Issue :

8

Database :

Complementary Index

Journal :

Journal of Surgical Oncology

Publication Type :

Academic Journal

Accession number :

153561917

Full Text :

https://doi.org/10.1002/jso.26646